TRAIN by Holi
TRAIN by Holi

TRAIN by Holi

Upcoming
IPT
Brain Longevity
$TRAIN

The first human trial that will tell you - with blood - which training actually grows your brain. 100 Berlin gym-goers. 2 training arms. 200+ BDNF blood draws. All data on-chain in real time. All revenue and dataset usage feed the Bio Protocol’s buyback & research-funding loop. 4300+ workouts already tracked. Now we ignite the next stage to reach longevity orbit.

Community Sentiment

How do you feel about this ipt?

...
No trend data
Project

Market Overview

$240 Billion
Global Fitness & Training Market in 2025
$150 Billion
Digital Health & AI-Fitness in 2025
$55 Billion
Decentralized Clinical Trials & RWE Platforms

Current Status

Our pilot phase is completed (4,000+ tracked workouts, proven VO2 max & body-comp gains) and $TRAIN token will fund the start of our BDNF trial in January 2026 (blood draws, lab analysis, and open-science infrastructure).

Summary

TRAIN by Holi is the first industrial-scale exercise-neuroscience engine producing multimodal datasets and licensable training protocols.

The first dataset is a head-to-head trial comparing velocity-focused vs. strength-focused training on chronic BDNF elevation and brain-health markers. Inside our fully owned Berlin GymLab (4,300+ tracked workouts, medical-grade equipment), 100 experienced members are randomized 1:1 into two 12-week arms. We perform 200 high-sensitivity plasma BDNF blood draws (baseline + week 12, standardized 24 h post-workout). Every participant receives continuous heart-rate monitoring during every session, and validated psychological batteries (e.g. PANAS, BRUMS, Cognitive Function Battery, Perceived Stress Scale, Pittsburgh Sleep Quality Index) at weeks 0, 4, 8, and 12. All raw data is published on-chain within 48 h. The superior protocol and full multimodal dataset become licensable IP governed and revenue-shared through the $TRAIN token.

Based on prior meta-analyses (n≈1,000+), we expect a between-group effect size in the range of g=0.35–0.55 for resting BDNF over 12 weeks. Our sample (n=100, 1:1 randomization) provides >80% power to detect group differences ≥0.4 at α=0.05. All plasma BDNF assays are processed by a certified clinical laboratory.

Problem

Today, no platform, app, clinic, or training system has comparative evidence for which training patterns reliably increase BDNF and brain-health markers over time. Velocity athletes and strength athletes have been arguing for decades about which style is better for the brain and longevity, yet no study has ever compared them directly in the same facility, with the same cohort, using gold-standard biomarkers. Existing BDNF research is almost entirely acute (<24 h), small-sample (n < 25), and ignores real-world variables like sleep, stress, and recovery — exactly what daily HRV, psychological batteries, and continuous heart-rate data solve. Trainers, apps, clinics, and longevity funds currently have zero comparative evidence to guide programming or investment.

Impact

TRAIN delivers the definitive answer: which training philosophy - explosive speed or maximal strength - drives larger, more sustained increases in resting BDNF, recovery capacity (HRV), mood, cognitive performance, and sleep architecture over 12 weeks. The multimodal dataset (BDNF + HRV time-series + heart-rate dynamics + psychometrics) instantly becomes the global benchmark for “brain-optimized training.” Because we own the gym and the data pipeline, we can run follow-up arms indefinitely (HIIT, Zone 2, concurrent, etc.) and keep compounding the most valuable longitudinal exercise-neuroscience dataset on Earth.

This study is designed for continuous iteration inside the DeSci standards. All assays, sensors, questionnaires, and workout streams follow DeSci’s reproducible-on-chain format (IP-NFT), enabling future cohorts (HIIT, Zone 2, concurrent, women-only, age-stratified) to reuse the same validated data pipeline without re-inventing operational overhead.

We operate Europe’s only fully instrumented GymLab capable of producing continuous physiological, psychological, and biomarker datasets at scale. No direct distributions to token holders occur; all value flows through automated buyback & burn and the Research Escrow.

Core Revenue Engine - Dataset & Protocol Licensing

The multimodal dataset (BDNF + HRV + heart rate dynamics + psychometric + training adherence) and the winning protocol are licensed to:

  • Wearables & health platforms
  • Coaching apps
  • Training marketplaces
  • AI physiology labs
  • Insurers and clinical partners

All other revenue exists only to reinforce dataset growth.

Secondary Reinforcement Stream might include $TRAIN Certified Development Journey (with training plans and certifications) and a proprietary High-Margin Supplement & Recovery Stack (in development)

Value Accrual to $TRAIN Token Holders

  • A fixed % of every licensing payment (dataset or protocol) flows into programmatic buyback & burn.
  • A second fixed % accumulates into the Research Escrow, automatically funding the next arms (HIIT, Zone 2, concurrent training, women-only cohorts, etc.).
  • The more the community trades, shares, and applies the protocol, the more liquidity and attention drive token demand.

This makes $TRAIN a pure function of dataset growth and protocol adoption. Because we own the gym, control the sensors, and publish every datapoint on-chain, every new cohort runs at near-100% marginal margin and grows the same dataset that drives token appreciation. No competitor can replicate this compounding loop without acquiring gyms, participants, assays, and a Bio Protocol launchpad.

Data & Replicability

Every new cohort increases temporal resolution, multimodal breadth, and follow-up depth of the same dataset - creating an irreversible data advantage that no competitor can reconstruct without identical gym ownership, participant access, assays, and on-chain infrastructure.

Once validated, the GymLab template can be cloned in other cities via partner gyms using the same measurement backbone, turning TRAIN into a distributed, revenue-generating research network.


Daniel A. García Rodríguez

Founder | Tech & Protocol Lead Exited Serial founder and technology strategist with deep experience in building complex, data-driven systems. Daniel founded RapidApe (acquired) and co-founded KREATIZE, a cloud manufacturing platform backed by leading European industrial and deep-tech investors. He serves on the Google Developer Advisory Board (GDAB), where he contributes to technical ecosystem strategy, cloud infrastructure evolution, and developer tooling. Daniel is a trainer with a focus on applied neuroscience, sensor-based training, and computational modeling of human performance. At Holi, he leads protocol architecture, data infrastructure, and the tokenized IP framework, integrating scientific insights with scalable product systems.

Robert Harting

Co-Founder | Elite Athlete Relations & Brand Olympic Gold Medalist (London 2012), three-time World Champion, trainer specializing in biomechanics, neuromuscular adaptation, and high-performance conditioning. Robert works with elite European athletes across Olympic disciplines and professional leagues, advising on load management, injury-resilience, and force-velocity profiling. He collaborates with federations, sports-science labs, and performance centers to translate research into field-ready training interventions. At Holi, he leads the applied performance validation of the BDNF Protocol, focusing on protocol fidelity, movement standards, and measurable physiological outcomes.

Holi Collective

Interdisciplinary team combining certified trainers, performance scientists and researchers from Charité, ML engineers, and product researchers and experts from OpenAI, Google and other leading tech companies. Members bring experience from elite training centers, university labs, and applied health-tech environments. The Collective develops AI-enabled gymlabs and executes micro-randomized trial, gym-based intervention studies, and continuous monitoring pipelines to analyze BDNF response patterns and neuroplasticity markers. Their work includes protocol standardization, sensor integration, data-quality assurance, and the development of tokenized IP assets derived from validated training methods. The group serves as the R&D engine behind the Holi BDNF Protocol, ensuring reproducibility, scientific rigor, and translational applicability across consumer and professional environments.

Q4 2025

Protocol Design Finalized

BDNF velocity-vs-strength clinical trial defined; ethics submission in progress

Q1 2026

Pilot Launch (Berlin GymLab)

Recruit 90 participants; execute 12-week trial; collect velocity + biomarker data

Tokenized Data Layer v1

Deploy on-chain dataset and participant reward system integrated with Holi App

Q3 2026

Partnership Expansion

Add 3–5 GymLabs across Europe (Munich, Zurich, Copenhagen) to replicate study

Q4 2026

Publication + IP Filing

Release preprint with Charité partners and file “velocity-based neuroplasticity training” patent

Protocol Token Launch

Launch $HOLI / study-specific tokens tied to dataset staking + rewards

Q1 2027

Global Expansion + New Trials

Scale to 25 GymLabs and launch next RWE studies (sleep, lactate, mitochondrial health)

Community
Feed
...

Stay up to date

Get the latest community updates and find out about upcoming TRAIN by Holi developments